Expert Review of Clinical Pharmacology

打开微信扫一扫

期刊ISSN

1751-2433

E-ISSN

1751-2441

影响因子

登录后查看数据

自引率

1.8%

SCI期刊JCR分区

SCI期刊JCR分区等级：2区

按学科分区
PHARMACOLOGY & PHARMACY Q2

最新中科院SCI期刊分区
（基础版）

大类学科	小类学科	Top期刊	综述期刊
医学 3区	药学 3区	否	是

最新中科院SCI期刊分区
（升级版）

大类学科	小类学科	Top期刊	综述期刊
医学 2区	药学 2区	否	是

期刊简介

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.

出版信息
出版商	Taylor and Francis Ltd.
期刊官网	http://www.tandfonline.com/toc/ierj20/current
涉及的研究方向	PHARMACOLOGY & PHARMACY-
年文章数	112
出版国家或地区	ENGLAND
是否OA	否
SCI期刊收录coverage	Science Citation Index Expanded (SCIE) Scopus (CiteScore)

Cite Score相关

Cite Score

SJR

SNIP

排名

6.8

0.927

1.181

学科	分区
大类学科：Pharmacology, Toxicology and Pharmaceutics 小类学科：General Pharmacology, Toxicology and Pharmaceutics	Q1
大类学科：Pharmacology, Toxicology and Pharmaceutics 小类学科：Pharmacology (medical)	Q1